Summary

The global Oncology and Cancer Treatment Drug market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
In 2025, the North America Oncology and Cancer Treatment Drug market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of Oncology and Cancer Treatment Drug include Roche, Novartis, Sanofi, Bayer, Merck & Co, Eli Lilly, Pfizer, Johnson & Johnson, Astellas, AbbVie, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global Oncology and Cancer Treatment Drug market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
Market Segmentation
By Company:
Roche
Novartis
Sanofi
Bayer
Merck & Co
Eli Lilly
Pfizer
Johnson & Johnson
Astellas
AbbVie
Teva
Otsuka
Amgen
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Sun Pharma
Accord Healthcare
SK Chemicals
Bristol-Myers Squibb
Takeda
Eisai
Biogen Idec
Segment by Type
Chemotherapy Drug
Targeted Drug
Immunotherapy Drug
Segment by Application
Benign Tumor
Cancer and Other Malignant Tumors
Macro-Region
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of Oncology and Cancer Treatment Drug sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of Oncology and Cancer Treatment Drug manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, Oncology and Cancer Treatment Drug product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Oncology and Cancer Treatment Drug value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

ページTOPに戻る

Table of Contents

1 Market Overview
1.1 Oncology and Cancer Treatment Drug Product Scope
1.2 Oncology and Cancer Treatment Drug by Type
1.2.1 Global Oncology and Cancer Treatment Drug Sales by Type (2021, 2025 & 2032)
1.2.2 Chemotherapy Drug
1.2.3 Targeted Drug
1.2.4 Immunotherapy Drug
1.3 Oncology and Cancer Treatment Drug by Application
1.3.1 Global Oncology and Cancer Treatment Drug Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 Benign Tumor
1.3.3 Cancer and Other Malignant Tumors
1.4 Global Oncology and Cancer Treatment Drug Market Estimates and Forecasts (2021-2032)
1.4.1 Global Oncology and Cancer Treatment Drug Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global Oncology and Cancer Treatment Drug Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global Oncology and Cancer Treatment Drug Price Trends (2021-2032)
1.5 Assumptions and Limitations

2 Market Size and Prospects by Region
2.1 Global Oncology and Cancer Treatment Drug Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global Oncology and Cancer Treatment Drug Historical Market Scenario by Region (2021-2026)
2.2.1 Global Oncology and Cancer Treatment Drug Sales Market Share by Region (2021-2026)
2.2.2 Global Oncology and Cancer Treatment Drug Revenue Market Share by Region (2021-2026)
2.3 Global Oncology and Cancer Treatment Drug Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global Oncology and Cancer Treatment Drug Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global Oncology and Cancer Treatment Drug Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America Oncology and Cancer Treatment Drug Market Size and Prospects (2021-2032)
2.4.2 Europe Oncology and Cancer Treatment Drug Market Size and Prospects (2021-2032)
2.4.3 China Oncology and Cancer Treatment Drug Market Size and Prospects (2021-2032)
2.4.4 Japan Oncology and Cancer Treatment Drug Market Size and Prospects (2021-2032)

3 Global Market Size by Type
3.1 Global Oncology and Cancer Treatment Drug Historical Market Review by Type (2021-2026)
3.1.1 Global Oncology and Cancer Treatment Drug Sales by Type (2021-2026)
3.1.2 Global Oncology and Cancer Treatment Drug Revenue by Type (2021-2026)
3.1.3 Global Oncology and Cancer Treatment Drug Average Price by Type (2021-2026)
3.2 Global Oncology and Cancer Treatment Drug Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global Oncology and Cancer Treatment Drug Sales Forecast by Type (2027-2032)
3.2.2 Global Oncology and Cancer Treatment Drug Revenue Forecast by Type (2027-2032)
3.2.3 Global Oncology and Cancer Treatment Drug Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of Oncology and Cancer Treatment Drug

4 Global Market Size by Application
4.1 Global Oncology and Cancer Treatment Drug Historical Market Review by Application (2021-2026)
4.1.1 Global Oncology and Cancer Treatment Drug Sales by Application (2021-2026)
4.1.2 Global Oncology and Cancer Treatment Drug Revenue by Application (2021-2026)
4.1.3 Global Oncology and Cancer Treatment Drug Average Price by Application (2021-2026)
4.2 Global Oncology and Cancer Treatment Drug Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global Oncology and Cancer Treatment Drug Sales Forecast by Application (2027-2032)
4.2.2 Global Oncology and Cancer Treatment Drug Revenue Forecast by Application (2027-2032)
4.2.3 Global Oncology and Cancer Treatment Drug Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in Oncology and Cancer Treatment Drug Applications

5 Competition Landscape by Players
5.1 Global Oncology and Cancer Treatment Drug Sales by Player (2021-2026)
5.2 Global Top Oncology and Cancer Treatment Drug Players by Revenue (2021-2026)
5.3 Global Oncology and Cancer Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on Oncology and Cancer Treatment Drug revenue as of 2025
5.4 Global Oncology and Cancer Treatment Drug Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of Oncology and Cancer Treatment Drug, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Oncology and Cancer Treatment Drug, Product Type & Application
5.7 Global Key Manufacturers of Oncology and Cancer Treatment Drug, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Oncology and Cancer Treatment Drug Sales by Company
6.1.1.1 North America Oncology and Cancer Treatment Drug Sales by Company (2021-2026)
6.1.1.2 North America Oncology and Cancer Treatment Drug Revenue by Company (2021-2026)
6.1.2 North America Oncology and Cancer Treatment Drug Sales Breakdown by Type (2021-2026)
6.1.3 North America Oncology and Cancer Treatment Drug Sales Breakdown by Application (2021-2026)
6.1.4 North America Oncology and Cancer Treatment Drug Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Oncology and Cancer Treatment Drug Sales by Company
6.2.1.1 Europe Oncology and Cancer Treatment Drug Sales by Company (2021-2026)
6.2.1.2 Europe Oncology and Cancer Treatment Drug Revenue by Company (2021-2026)
6.2.2 Europe Oncology and Cancer Treatment Drug Sales Breakdown by Type (2021-2026)
6.2.3 Europe Oncology and Cancer Treatment Drug Sales Breakdown by Application (2021-2026)
6.2.4 Europe Oncology and Cancer Treatment Drug Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Oncology and Cancer Treatment Drug Sales by Company
6.3.1.1 China Oncology and Cancer Treatment Drug Sales by Company (2021-2026)
6.3.1.2 China Oncology and Cancer Treatment Drug Revenue by Company (2021-2026)
6.3.2 China Oncology and Cancer Treatment Drug Sales Breakdown by Type (2021-2026)
6.3.3 China Oncology and Cancer Treatment Drug Sales Breakdown by Application (2021-2026)
6.3.4 China Oncology and Cancer Treatment Drug Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Oncology and Cancer Treatment Drug Sales by Company
6.4.1.1 Japan Oncology and Cancer Treatment Drug Sales by Company (2021-2026)
6.4.1.2 Japan Oncology and Cancer Treatment Drug Revenue by Company (2021-2026)
6.4.2 Japan Oncology and Cancer Treatment Drug Sales Breakdown by Type (2021-2026)
6.4.3 Japan Oncology and Cancer Treatment Drug Sales Breakdown by Application (2021-2026)
6.4.4 Japan Oncology and Cancer Treatment Drug Major Customers
6.4.5 Japan Market Trends and Opportunities

7 Company Profiles and Key Figures
7.1 Roche
7.1.1 Roche Company Information
7.1.2 Roche Business Overview
7.1.3 Roche Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.1.4 Roche Oncology and Cancer Treatment Drug Products Offered
7.1.5 Roche Recent Development
7.2 Novartis
7.2.1 Novartis Company Information
7.2.2 Novartis Business Overview
7.2.3 Novartis Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Novartis Oncology and Cancer Treatment Drug Products Offered
7.2.5 Novartis Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Information
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Sanofi Oncology and Cancer Treatment Drug Products Offered
7.3.5 Sanofi Recent Development
7.4 Bayer
7.4.1 Bayer Company Information
7.4.2 Bayer Business Overview
7.4.3 Bayer Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.4.4 Bayer Oncology and Cancer Treatment Drug Products Offered
7.4.5 Bayer Recent Development
7.5 Merck & Co
7.5.1 Merck & Co Company Information
7.5.2 Merck & Co Business Overview
7.5.3 Merck & Co Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Merck & Co Oncology and Cancer Treatment Drug Products Offered
7.5.5 Merck & Co Recent Development
7.6 Eli Lilly
7.6.1 Eli Lilly Company Information
7.6.2 Eli Lilly Business Overview
7.6.3 Eli Lilly Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Eli Lilly Oncology and Cancer Treatment Drug Products Offered
7.6.5 Eli Lilly Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Information
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Pfizer Oncology and Cancer Treatment Drug Products Offered
7.7.5 Pfizer Recent Development
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Information
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Johnson & Johnson Oncology and Cancer Treatment Drug Products Offered
7.8.5 Johnson & Johnson Recent Development
7.9 Astellas
7.9.1 Astellas Company Information
7.9.2 Astellas Business Overview
7.9.3 Astellas Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Astellas Oncology and Cancer Treatment Drug Products Offered
7.9.5 Astellas Recent Development
7.10 AbbVie
7.10.1 AbbVie Company Information
7.10.2 AbbVie Business Overview
7.10.3 AbbVie Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.10.4 AbbVie Oncology and Cancer Treatment Drug Products Offered
7.10.5 AbbVie Recent Development
7.11 Teva
7.11.1 Teva Company Information
7.11.2 Teva Business Overview
7.11.3 Teva Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Teva Oncology and Cancer Treatment Drug Products Offered
7.11.5 Teva Recent Development
7.12 Otsuka
7.12.1 Otsuka Company Information
7.12.2 Otsuka Business Overview
7.12.3 Otsuka Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Otsuka Oncology and Cancer Treatment Drug Products Offered
7.12.5 Otsuka Recent Development
7.13 Amgen
7.13.1 Amgen Company Information
7.13.2 Amgen Business Overview
7.13.3 Amgen Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Amgen Oncology and Cancer Treatment Drug Products Offered
7.13.5 Amgen Recent Development
7.14 Yi Bai Pharmaceutical
7.14.1 Yi Bai Pharmaceutical Company Information
7.14.2 Yi Bai Pharmaceutical Business Overview
7.14.3 Yi Bai Pharmaceutical Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Yi Bai Pharmaceutical Oncology and Cancer Treatment Drug Products Offered
7.14.5 Yi Bai Pharmaceutical Recent Development
7.15 Qilu Pharmaceutical
7.15.1 Qilu Pharmaceutical Company Information
7.15.2 Qilu Pharmaceutical Business Overview
7.15.3 Qilu Pharmaceutical Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.15.4 Qilu Pharmaceutical Oncology and Cancer Treatment Drug Products Offered
7.15.5 Qilu Pharmaceutical Recent Development
7.16 Sun Pharma
7.16.1 Sun Pharma Company Information
7.16.2 Sun Pharma Business Overview
7.16.3 Sun Pharma Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.16.4 Sun Pharma Oncology and Cancer Treatment Drug Products Offered
7.16.5 Sun Pharma Recent Development
7.17 Accord Healthcare
7.17.1 Accord Healthcare Company Information
7.17.2 Accord Healthcare Business Overview
7.17.3 Accord Healthcare Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.17.4 Accord Healthcare Oncology and Cancer Treatment Drug Products Offered
7.17.5 Accord Healthcare Recent Development
7.18 SK Chemicals
7.18.1 SK Chemicals Company Information
7.18.2 SK Chemicals Business Overview
7.18.3 SK Chemicals Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.18.4 SK Chemicals Oncology and Cancer Treatment Drug Products Offered
7.18.5 SK Chemicals Recent Development
7.19 Bristol-Myers Squibb
7.19.1 Bristol-Myers Squibb Company Information
7.19.2 Bristol-Myers Squibb Business Overview
7.19.3 Bristol-Myers Squibb Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.19.4 Bristol-Myers Squibb Oncology and Cancer Treatment Drug Products Offered
7.19.5 Bristol-Myers Squibb Recent Development
7.20 Takeda
7.20.1 Takeda Company Information
7.20.2 Takeda Business Overview
7.20.3 Takeda Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.20.4 Takeda Oncology and Cancer Treatment Drug Products Offered
7.20.5 Takeda Recent Development
7.21 Eisai
7.21.1 Eisai Company Information
7.21.2 Eisai Business Overview
7.21.3 Eisai Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.21.4 Eisai Oncology and Cancer Treatment Drug Products Offered
7.21.5 Eisai Recent Development
7.22 Biogen Idec
7.22.1 Biogen Idec Company Information
7.22.2 Biogen Idec Business Overview
7.22.3 Biogen Idec Oncology and Cancer Treatment Drug Sales, Revenue and Gross Margin (2021-2026)
7.22.4 Biogen Idec Oncology and Cancer Treatment Drug Products Offered
7.22.5 Biogen Idec Recent Development

8 Oncology and Cancer Treatment Drug Manufacturing Cost Analysis
8.1 Oncology and Cancer Treatment Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Oncology and Cancer Treatment Drug
8.4 Oncology and Cancer Treatment Drug Industrial Chain Analysis

9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 Oncology and Cancer Treatment Drug Distributors List
9.3 Oncology and Cancer Treatment Drug Customers

10 Oncology and Cancer Treatment Drug Market Dynamics
10.1 Oncology and Cancer Treatment Drug Industry Trends
10.2 Oncology and Cancer Treatment Drug Market Drivers
10.3 Oncology and Cancer Treatment Drug Market Challenges
10.4 Oncology and Cancer Treatment Drug Market Restraints

11 Research Findings and Conclusion

12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Oncology and Cancer Treatment Drug Sales (US$ Million) Growth Rate by Type (2021, 2025 & 2032)
Table 2. Global Oncology and Cancer Treatment Drug Sales (US$ Million) Comparison by Application (2021, 2025 & 2032)
Table 3. Global Market Oncology and Cancer Treatment Drug Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Table 4. Global Oncology and Cancer Treatment Drug Sales (K Units) by Region (2021-2026)
Table 5. Global Oncology and Cancer Treatment Drug Sales Market Share by Region (2021-2026)
Table 6. Global Oncology and Cancer Treatment Drug Revenue (US$ Million) Market Share by Region (2021-2026)
Table 7. Global Oncology and Cancer Treatment Drug Revenue Share by Region (2021-2026)
Table 8. Global Oncology and Cancer Treatment Drug Sales (K Units) Forecast by Region (2027-2032)
Table 9. Global Oncology and Cancer Treatment Drug Sales Market Share Forecast by Region (2027-2032)
Table 10. Global Oncology and Cancer Treatment Drug Revenue (US$ Million) Forecast by Region (2027-2032)
Table 11. Global Oncology and Cancer Treatment Drug Revenue Share Forecast by Region (2027-2032)
Table 12. Global Oncology and Cancer Treatment Drug Sales by Type (K Units) & (2021-2026)
Table 13. Global Oncology and Cancer Treatment Drug Sales Share by Type (2021-2026)
Table 14. Global Oncology and Cancer Treatment Drug Revenue by Type (US$ Million) & (2021-2026)
Table 15. Global Oncology and Cancer Treatment Drug Average Price by Type (US$/Unit) & (2021-2026)
Table 16. Global Oncology and Cancer Treatment Drug Sales by Type (K Units) & (2027-2032)
Table 17. Global Oncology and Cancer Treatment Drug Revenue by Type (US$ Million) & (2027-2032)
Table 18. Global Oncology and Cancer Treatment Drug Average Price by Type (US$/Unit) & (2027-2032)
Table 19. Representative Players of Each Type
Table 20. Global Oncology and Cancer Treatment Drug Sales by Application (K Units) & (2021-2026)
Table 21. Global Oncology and Cancer Treatment Drug Sales Share by Application (2021-2026)
Table 22. Global Oncology and Cancer Treatment Drug Revenue by Application (US$ Million) & (2021-2026)
Table 23. Global Oncology and Cancer Treatment Drug Average Price by Application (US$/Unit) & (2021-2026)
Table 24. Global Oncology and Cancer Treatment Drug Sales by Application (K Units) & (2027-2032)
Table 25. Global Oncology and Cancer Treatment Drug Revenue Market Share by Application (US$ Million) & (2027-2032)
Table 26. Global Oncology and Cancer Treatment Drug Average Price by Application (US$/Unit) & (2027-2032)
Table 27. New Sources of Growth in Oncology and Cancer Treatment Drug Applications
Table 28. Global Oncology and Cancer Treatment Drug Sales by Company (K Units) & (2021-2026)
Table 29. Global Oncology and Cancer Treatment Drug Sales Share by Company (2021-2026)
Table 30. Global Oncology and Cancer Treatment Drug Revenue by Company (US$ Million) & (2021-2026)
Table 31. Global Oncology and Cancer Treatment Drug Revenue Share by Company (2021-2026)
Table 32. Global Oncology and Cancer Treatment Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology and Cancer Treatment Drug as of 2025)
Table 33. Global Market Oncology and Cancer Treatment Drug Average Price by Company (US$/Unit) & (2021-2026)
Table 34. Global Key Manufacturers of Oncology and Cancer Treatment Drug, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Oncology and Cancer Treatment Drug, Product Type & Application
Table 36. Global Key Manufacturers of Oncology and Cancer Treatment Drug, Date of Entry into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Oncology and Cancer Treatment Drug Sales by Company (2021-2026) & (K Units)
Table 39. North America Oncology and Cancer Treatment Drug Sales Market Share by Company (2021-2026)
Table 40. North America Oncology and Cancer Treatment Drug Revenue by Company (2021-2026) & (US$ Million)
Table 41. North America Oncology and Cancer Treatment Drug Revenue Market Share by Company (2021-2026)
Table 42. North America Oncology and Cancer Treatment Drug Sales by Type (2021-2026) & (K Units)
Table 43. North America Oncology and Cancer Treatment Drug Sales Market Share by Type (2021-2026)
Table 44. North America Oncology and Cancer Treatment Drug Sales by Application (2021-2026) & (K Units)
Table 45. North America Oncology and Cancer Treatment Drug Sales Market Share by Application (2021-2026)
Table 46. Europe Oncology and Cancer Treatment Drug Sales by Company (2021-2026) & (K Units)
Table 47. Europe Oncology and Cancer Treatment Drug Sales Market Share by Company (2021-2026)
Table 48. Europe Oncology and Cancer Treatment Drug Revenue by Company (2021-2026) & (US$ Million)
Table 49. Europe Oncology and Cancer Treatment Drug Revenue Market Share by Company (2021-2026)
Table 50. Europe Oncology and Cancer Treatment Drug Sales by Type (2021-2026) & (K Units)
Table 51. Europe Oncology and Cancer Treatment Drug Sales Market Share by Type (2021-2026)
Table 52. Europe Oncology and Cancer Treatment Drug Sales by Application (2021-2026) & (K Units)
Table 53. Europe Oncology and Cancer Treatment Drug Sales Market Share by Application (2021-2026)
Table 54. China Oncology and Cancer Treatment Drug Sales by Company (2021-2026) & (K Units)
Table 55. China Oncology and Cancer Treatment Drug Sales Market Share by Company (2021-2026)
Table 56. China Oncology and Cancer Treatment Drug Revenue by Company (2021-2026) & (US$ Million)
Table 57. China Oncology and Cancer Treatment Drug Revenue Market Share by Company (2021-2026)
Table 58. China Oncology and Cancer Treatment Drug Sales by Type (2021-2026) & (K Units)
Table 59. China Oncology and Cancer Treatment Drug Sales Market Share by Type (2021-2026)
Table 60. China Oncology and Cancer Treatment Drug Sales by Application (2021-2026) & (K Units)
Table 61. China Oncology and Cancer Treatment Drug Sales Market Share by Application (2021-2026)
Table 62. Japan Oncology and Cancer Treatment Drug Sales by Company (2021-2026) & (K Units)
Table 63. Japan Oncology and Cancer Treatment Drug Sales Market Share by Company (2021-2026)
Table 64. Japan Oncology and Cancer Treatment Drug Revenue by Company (2021-2026) & (US$ Million)
Table 65. Japan Oncology and Cancer Treatment Drug Revenue Market Share by Company (2021-2026)
Table 66. Japan Oncology and Cancer Treatment Drug Sales by Type (2021-2026) & (K Units)
Table 67. Japan Oncology and Cancer Treatment Drug Sales Market Share by Type (2021-2026)
Table 68. Japan Oncology and Cancer Treatment Drug Sales by Application (2021-2026) & (K Units)
Table 69. Japan Oncology and Cancer Treatment Drug Sales Market Share by Application (2021-2026)
Table 70. Roche Company Information
Table 71. Roche Description and Business Overview
Table 72. Roche Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 73. Roche Oncology and Cancer Treatment Drug Product
Table 74. Roche Recent Development
Table 75. Novartis Company Information
Table 76. Novartis Description and Business Overview
Table 77. Novartis Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 78. Novartis Oncology and Cancer Treatment Drug Product
Table 79. Novartis Recent Development
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 83. Sanofi Oncology and Cancer Treatment Drug Product
Table 84. Sanofi Recent Development
Table 85. Bayer Company Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 88. Bayer Oncology and Cancer Treatment Drug Product
Table 89. Bayer Recent Development
Table 90. Merck & Co Company Information
Table 91. Merck & Co Description and Business Overview
Table 92. Merck & Co Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 93. Merck & Co Oncology and Cancer Treatment Drug Product
Table 94. Merck & Co Recent Development
Table 95. Eli Lilly Company Information
Table 96. Eli Lilly Description and Business Overview
Table 97. Eli Lilly Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 98. Eli Lilly Oncology and Cancer Treatment Drug Product
Table 99. Eli Lilly Recent Development
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Pfizer Oncology and Cancer Treatment Drug Product
Table 104. Pfizer Recent Development
Table 105. Johnson & Johnson Company Information
Table 106. Johnson & Johnson Description and Business Overview
Table 107. Johnson & Johnson Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 108. Johnson & Johnson Oncology and Cancer Treatment Drug Product
Table 109. Johnson & Johnson Recent Development
Table 110. Astellas Company Information
Table 111. Astellas Description and Business Overview
Table 112. Astellas Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 113. Astellas Oncology and Cancer Treatment Drug Product
Table 114. Astellas Recent Development
Table 115. AbbVie Company Information
Table 116. AbbVie Description and Business Overview
Table 117. AbbVie Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 118. AbbVie Oncology and Cancer Treatment Drug Product
Table 119. AbbVie Recent Development
Table 120. Teva Company Information
Table 121. Teva Description and Business Overview
Table 122. Teva Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 123. Teva Oncology and Cancer Treatment Drug Product
Table 124. Teva Recent Development
Table 125. Otsuka Company Information
Table 126. Otsuka Description and Business Overview
Table 127. Otsuka Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 128. Otsuka Oncology and Cancer Treatment Drug Product
Table 129. Otsuka Recent Development
Table 130. Amgen Company Information
Table 131. Amgen Description and Business Overview
Table 132. Amgen Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 133. Amgen Oncology and Cancer Treatment Drug Product
Table 134. Amgen Recent Development
Table 135. Yi Bai Pharmaceutical Company Information
Table 136. Yi Bai Pharmaceutical Description and Business Overview
Table 137. Yi Bai Pharmaceutical Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 138. Yi Bai Pharmaceutical Oncology and Cancer Treatment Drug Product
Table 139. Yi Bai Pharmaceutical Recent Development
Table 140. Qilu Pharmaceutical Company Information
Table 141. Qilu Pharmaceutical Description and Business Overview
Table 142. Qilu Pharmaceutical Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 143. Qilu Pharmaceutical Oncology and Cancer Treatment Drug Product
Table 144. Qilu Pharmaceutical Recent Development
Table 145. Sun Pharma Company Information
Table 146. Sun Pharma Description and Business Overview
Table 147. Sun Pharma Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 148. Sun Pharma Oncology and Cancer Treatment Drug Product
Table 149. Sun Pharma Recent Development
Table 150. Accord Healthcare Company Information
Table 151. Accord Healthcare Description and Business Overview
Table 152. Accord Healthcare Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 153. Accord Healthcare Oncology and Cancer Treatment Drug Product
Table 154. Accord Healthcare Recent Development
Table 155. SK Chemicals Company Information
Table 156. SK Chemicals Description and Business Overview
Table 157. SK Chemicals Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 158. SK Chemicals Oncology and Cancer Treatment Drug Product
Table 159. SK Chemicals Recent Development
Table 160. Bristol-Myers Squibb Company Information
Table 161. Bristol-Myers Squibb Description and Business Overview
Table 162. Bristol-Myers Squibb Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 163. Bristol-Myers Squibb Oncology and Cancer Treatment Drug Product
Table 164. Bristol-Myers Squibb Recent Development
Table 165. Takeda Company Information
Table 166. Takeda Description and Business Overview
Table 167. Takeda Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 168. Takeda Oncology and Cancer Treatment Drug Product
Table 169. Takeda Recent Development
Table 170. Eisai Company Information
Table 171. Eisai Description and Business Overview
Table 172. Eisai Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 173. Eisai Oncology and Cancer Treatment Drug Product
Table 174. Eisai Recent Development
Table 175. Biogen Idec Company Information
Table 176. Biogen Idec Description and Business Overview
Table 177. Biogen Idec Oncology and Cancer Treatment Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 178. Biogen Idec Oncology and Cancer Treatment Drug Product
Table 179. Biogen Idec Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Oncology and Cancer Treatment Drug Distributors List
Table 183. Oncology and Cancer Treatment Drug Customers List
Table 184. Oncology and Cancer Treatment Drug Market Trends
Table 185. Oncology and Cancer Treatment Drug Market Drivers
Table 186. Oncology and Cancer Treatment Drug Market Challenges
Table 187. Oncology and Cancer Treatment Drug Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources

List of Figures
Figure 1. Oncology and Cancer Treatment Drug Product Picture
Figure 2. Global Oncology and Cancer Treatment Drug Sales (US$ Million) by Type (2021, 2025 & 2032)
Figure 3. Global Oncology and Cancer Treatment Drug Sales Market Share by Type in 2025 & 2032
Figure 4. Chemotherapy Drug Product Picture
Figure 5. Targeted Drug Product Picture
Figure 6. Immunotherapy Drug Product Picture
Figure 7. Global Oncology and Cancer Treatment Drug Sales (US$ Million) by Application (2021, 2025 & 2032)
Figure 8. Global Oncology and Cancer Treatment Drug Sales Market Share by Application in 2025 & 2032
Figure 9. Benign Tumor Examples
Figure 10. Cancer and Other Malignant Tumors Examples
Figure 11. Global Oncology and Cancer Treatment Drug Sales, (US$ Million), 2021 VS 2025 VS 2032
Figure 12. Global Oncology and Cancer Treatment Drug Sales Growth Rate (2021-2032) & (US$ Million)
Figure 13. Global Oncology and Cancer Treatment Drug Sales (K Units) Growth Rate (2021-2032)
Figure 14. Global Oncology and Cancer Treatment Drug Price Trends Growth Rate (2021-2032) & (US$/Unit)
Figure 15. Oncology and Cancer Treatment Drug Report Years Considered
Figure 16. Global Market Oncology and Cancer Treatment Drug Market Size (US$ Million) by Region:2021 VS 2025 VS 2032
Figure 17. Global Oncology and Cancer Treatment Drug Revenue Market Share by Region: 2021 VS 2025
Figure 18. North America Oncology and Cancer Treatment Drug Revenue (US$ Million) Growth Rate (2021-2032)
Figure 19. North America Oncology and Cancer Treatment Drug Sales (K Units) Growth Rate (2021-2032)
Figure 20. Europe Oncology and Cancer Treatment Drug Revenue (US$ Million) Growth Rate (2021-2032)
Figure 21. Europe Oncology and Cancer Treatment Drug Sales (K Units) Growth Rate (2021-2032)
Figure 22. China Oncology and Cancer Treatment Drug Revenue (US$ Million) Growth Rate (2021-2032)
Figure 23. China Oncology and Cancer Treatment Drug Sales (K Units) Growth Rate (2021-2032)
Figure 24. Japan Oncology and Cancer Treatment Drug Revenue (US$ Million) Growth Rate (2021-2032)
Figure 25. Japan Oncology and Cancer Treatment Drug Sales (K Units) Growth Rate (2021-2032)
Figure 26. Global Oncology and Cancer Treatment Drug Revenue Share by Type (2021-2026)
Figure 27. Global Oncology and Cancer Treatment Drug Sales Share by Type (2027-2032)
Figure 28. Global Oncology and Cancer Treatment Drug Revenue Share by Type (2027-2032)
Figure 29. Global Oncology and Cancer Treatment Drug Revenue Share by Application (2021-2026)
Figure 30. Global Oncology and Cancer Treatment Drug Revenue Market Share by Application in 2021 & 2025
Figure 31. Global Oncology and Cancer Treatment Drug Sales Share by Application (2027-2032)
Figure 32. Global Oncology and Cancer Treatment Drug Revenue Share by Application (2027-2032)
Figure 33. Global Oncology and Cancer Treatment Drug Sales Share by Company (2025)
Figure 34. Global Oncology and Cancer Treatment Drug Revenue Share by Company (2025)
Figure 35. Global 5 Largest Oncology and Cancer Treatment Drug Players Market Share by Revenue in Oncology and Cancer Treatment Drug: 2021 & 2025
Figure 36. Oncology and Cancer Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 37. Manufacturing Cost Structure of Oncology and Cancer Treatment Drug
Figure 38. Manufacturing Process Analysis of Oncology and Cancer Treatment Drug
Figure 39. Oncology and Cancer Treatment Drug Industrial Chain
Figure 40. Channels of Distribution (Direct Vs Distribution)
Figure 41. Distributors Profiles
Figure 42. Bottom-up and Top-down Approaches for This Report
Figure 43. Data Triangulation
Figure 44. Key Executives Interviewed